Share your thoughts on multi-cancer detection tests and what role they might have, or not, for ovarian cancer? OCRA’s Scientific Advisory Committee (SAC) is comprised of doctors and researchers who are well-known and well-respected experts in the field of gynecologic oncology. They review the proposals we receive for research funding — hundreds of letters of … Continued
Being a professional athlete takes immense focus and determination — traits that pro golfer and defending champion of the U.S. Senior Women’s Open Jill McGill is harnessing to take on a challenge of another type: raising awareness about ovarian cancer. Her motivation? Two of the people whom she holds most dear. “My sister is a … Continued
Diagnosed with ovarian cancer in 2022, Marsha Biven currently participates in a number of OCRA programs, including Staying Connected, Survivors Teaching Students, and Woman to Woman. Read on to learn more about her story, including how a vision board (and a rogue parakeet!) factored into her experience and why her professional background is an asset … Continued
This action alert has now expired. This shortage of chemotherapy drugs, including cisplatin and carboplatin, has reached a serious level, impacting the treatment options available to some ovarian cancer patients. But you can help. In response, Representatives Ami Bera (D-CA), Mike Kelly (R-PA), Derek Kilmer (D-WA), and Brian Fitzpatrick (R-PA) have authored a Dear Colleague … Continued
What to Know About the Chemotherapy Drug Shortage As many are aware, the U.S. is currently experiencing a matter of great concern: an ongoing shortage of chemotherapy drugs that are essential in the treatment of ovarian cancer. The availability of these medications is of critical importance to patients and their families, and we understand the anxiety … Continued
OCRA is thrilled to announce TWO new support offerings for the summer of 2023, in addition to our year-round Staying Connected virtual support group programming! Learn more about our returning weekly series, and brand new monthly series, below. Registration is required to participate. Space is limited, so don’t wait! Staying Connected: Summer Roundtables First Wednesday … Continued
As many are aware, the United States is currently experiencing a matter of great concern: an ongoing shortage of chemotherapy drugs that are essential in the treatment of ovarian cancer. The availability of these medications is of critical importance to patients and their families, and we understand the anxiety and uncertainty this shortage may cause. … Continued
We are shining the spotlight on Jennifer Underwood this month, an OCRA Hero who has taken the lessons her late mother taught her and transformed them into concrete actions to help the ovarian cancer community. “She was selfless and kind, thoughtful and generous, wise and energetic — she was truly amazing,” Jennifer said of her … Continued
Three cheers for a collegiate group of OCRA Heroes who have put in time and energy to raise critical funds for ovarian cancer research. A field hockey team, a pharmaceutical fraternity, and a management class student all showed up and showed their support for our community in separate efforts over the past year. Read on … Continued
We know that germline genetic testing (testing that looks for inherited genetic mutations that exist in all cells of the body) is a crucial component in the fight against ovarian cancer — not just in determining who is at increased risk for the disease, but in optimizing treatment for patients already diagnosed. OCRA offers free … Continued
Written by Annie Ellis, OCRA Research Advocate and Scientific Advisory Committee member, and ovarian cancer survivor, based on expert presentations from the 2023 Annual Meeting of the Society of Gynecoologic Oncology. This year’s SGO annual meeting theme was Patients ● Purpose ● Progress. The meeting was held in Tampa, Florida from March 25th – 28th. … Continued
What can be gained by increasing our understanding of other gynecologic cancers or other parts of the female reproductive system? OCRA’s Scientific Advisory Committee (SAC) is comprised of doctors and researchers who are well-known and well-respected experts in the field of gynecologic oncology. They review the proposals we receive for research funding — hundreds of … Continued
Get email updates about research news, action alerts, and ways to join the fight.
